NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global antacids market size is estimated to grow by USD 692.3 million from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 3.27% during the forecast period. Rising geriatric population is driving market growth, with a trend towards growing e-commerce market.
However, adverse effect of prolonged use of antacids poses a challenge.Key market players include Advance Pharmaceutical Inc., AmerisourceBergen Corp.
, Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., inovapharma.
com , Johnson and Johnson Services Inc., Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc.
, Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., The Procter and Gamble Co.
, United Natural Foods Inc., and WellSpring Pharmaceutical Corp..
Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF Antacids Market Scope Report Coverage Details Base year 2023 Historic period 2018 - 2022 Forecast period 2024-2028 Growth momentum & CAGR Accelerate at a CAGR of 3.27% Market growth 2024-2028 USD 692.
3 million Market structure Fragmented YoY growth 2022-2023 (%) 3.13 Regional analysis North America, Europe, Asia, and Rest of World (ROW) Performing market contribution North America at 43% Key countries US, Germany, Canada, UK, and Brazil Key companies pro.
